These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29346367)

  • 21. Comparative plasma disposition kinetics of albendazole and its new benzimidazol prodrug in dog.
    Khalil Z; El Karbane M; Faouzi ME; Ansar M; Azougagh M; El Harti J; Taoufik J
    Ann Pharm Fr; 2016 Jan; 74(1):21-6. PubMed ID: 26530448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Albendazole treatment in laying hens: Egg residues and its effects on fertility and hatchability.
    Moreno L; Bistoletti M; Fernández H; Cantón L; Ceballos L; Cantón C; Lanusse C; Álvarez LI
    J Vet Pharmacol Ther; 2018 Oct; 41(5):726-733. PubMed ID: 29894001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albendazole failure to control resistant nematodes in lambs: lack of effect of fasting-induced improvement on drug absorption.
    Alvarez L; Entrocasso C; Lifschitz A; Manazza J; Ceballos L; Borda B; Lanusse C
    J Parasitol; 2010 Dec; 96(6):1204-10. PubMed ID: 21158637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime.
    López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F
    Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albendazole metabolites excretion in human saliva as a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs.
    Nieves E; Cimino R; Krolewiecki A; Juarez M; Lanusse C; Alvarez L; Ceballos L
    Sci Rep; 2024 Mar; 14(1):6271. PubMed ID: 38491091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of feeding on the plasma disposition kinetics of the anthelmintic albendazole in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    Br Poult Sci; 2014; 55(6):824-9. PubMed ID: 25159169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in plasma and abomasal kinetics of albendazole and its metabolites in calves grazed on pasture or fed a grain-based diet.
    Sánchez S; Alvarez L; Pis A; Quiroga M; Lanusse C
    Res Vet Sci; 1999 Jun; 66(3):223-30. PubMed ID: 10333463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced plasma and target tissue availabilities of albendazole and albendazole sulphoxide in fasted calves: evaluation of different fasting intervals.
    Sánchez S; Alvarez L; Sallovitz J; Lanusse C
    J Vet Pharmacol Ther; 2000 Aug; 23(4):193-201. PubMed ID: 11126322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albendazole sulphoxide kinetic disposition after treatment with different formulations in dogs.
    Dib A; Palma S; Suárez G; Farías C; Cabrera P; Castro S; Allemandi D; Moreno L; Lanusse C; Sánchez Bruni S
    J Vet Pharmacol Ther; 2011 Apr; 34(2):136-41. PubMed ID: 21395604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplacental transport of netobimin metabolites in ewes.
    Cristofol C; Carretero A; Fernandez M; Navarro M; Sautet J; Ruberte J; Arboix M
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):167-71. PubMed ID: 8751036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced plasma availability of the metabolites of albendazole in fasted adult sheep.
    Lifschitz A; Virkel G; Mastromarino M; Lanusse C
    Vet Res Commun; 1997 Apr; 21(3):201-11. PubMed ID: 9090047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
    Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
    Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of netobimin, albendazole, and its metabolites in the pregnant rat: developmental toxicity.
    Cristòfol C; Navarro M; Franquelo C; Valladares JE; Carretero A; Ruberte J; Arboix M
    Toxicol Appl Pharmacol; 1997 May; 144(1):56-61. PubMed ID: 9169069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and tissue residues of albendazole sulphoxide and its metabolites in donkey after intramuscular injection.
    Li Z; Qin X; Wang C; Liu W
    Vet Med Sci; 2024 May; 10(3):e1393. PubMed ID: 38640108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methimazole-mediated modulation of netobimin biotransformation in sheep: a pharmacokinetic assessment.
    Lanusse CE; Gascon L; Prichard RK
    J Vet Pharmacol Ther; 1992 Sep; 15(3):267-74. PubMed ID: 1433490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative drug systemic exposure and clinical efficacy against resistant nematodes in lambs treated with different albendazole formulations.
    Suárez G; Alvarez L; Castells D; Correa O; Fagiolino P; Lanusse C
    J Vet Pharmacol Ther; 2011 Dec; 34(6):557-64. PubMed ID: 21371047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion study and estimation of the withdrawal period for albendazole in tambaqui (
    Pereira Cordeiro R; Aparecida de Campos Braga P; Souza Rocha MJ; Campos Chagas E; Reyes Reyes FG
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2021 Nov; 38(11):1883-1896. PubMed ID: 34477497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.